Perception of the regulatory change for Zolpidem prescription by French general practitioners and its relation to prescription behavior
EJ Laforgue, M Istvan, B Schreck, M Mainguy… - Journal of Clinical …, 2022 - mdpi.com
Background: To “limit the risk of abuse and misuse” and “encourage correct usage”, the
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
French drug regulatory authority stated that—from April 2017—zolpidem prescription must …
Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users
EJ Laforgue, M Rousselet, A Claudon… - International Journal of …, 2022 - mdpi.com
Background: The French national drug regulatory authority stated, in 2017, that a secured
prescription pad must be used for zolpidem prescriptions. This study aimed to evaluate the …
prescription pad must be used for zolpidem prescriptions. This study aimed to evaluate the …
Consequences of the new zolpidem prescription regulations: a cohort study from the French national healthcare database
J Touchard, P Sabatier, G Airagnes, S Berdot… - European Journal of …, 2020 - Springer
Purpose To determine changes in the prevalence of zolpidem consumption since the
change in the regulations of prescription. Formulations containing zolpidem were subject to …
change in the regulations of prescription. Formulations containing zolpidem were subject to …
Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database
M Istvan, M Rousselet, EJ Laforgue… - Expert Opinion on …, 2022 - Taylor & Francis
Background In recent years, zolpidem has been the subject of numerous reports of misuse,
abuse and dependence. In view of these risks, the French drug agency decreed the …
abuse and dependence. In view of these risks, the French drug agency decreed the …
Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study
M Istvan, P Caillet, M Rousselet… - British Journal of …, 2021 - Wiley Online Library
Aims In recent years, zolpidem has been the subject of numerous reports of misuse, abuse
and dependence. In view of these risks, the French drug agency (ANSM) decreed in April …
and dependence. In view of these risks, the French drug agency (ANSM) decreed in April …
French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug …
M Gérardin, M Rousselet, P Caillet, M Grall-Bronnec… - BMJ open, 2019 - bmjopen.bmj.com
Introduction In recent years, data collected by the French Addictovigilance Network have
shown the potential for abuse and addiction associated with zolpidem (the most sold …
shown the potential for abuse and addiction associated with zolpidem (the most sold …
Regulatory framework implementation for the prescription of zolpidem in France, what impact in the older people?
A Jobert, M Istvan, EJ Laforgue, B Schreck… - International Journal of …, 2021 - mdpi.com
Background: Zolpidem is one of the most prescribed hypnotic drugs. In 2001, the World
Health Organization alerted a risk of pharmacodependence associated with zolpidem. The …
Health Organization alerted a risk of pharmacodependence associated with zolpidem. The …
Prevalence of zolpidem use in France halved after secure prescription pads implementation in 2017: A SNDS database nested cohort study
Our objective was to quantify the impact on the use of zolpidem of the obligation
implemented in France in 2017 to use secure prescription pads to prescribe it. We …
implemented in France in 2017 to use secure prescription pads to prescribe it. We …
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory …
A Aquizerate, EJ Laforgue, M Istvan… - European Journal of …, 2023 - academic.oup.com
Background Since the appearance of zolpidem on the market, the occurrence of serious
cases of abuse, misuse and dependence have come to the attention of authorities. In view of …
cases of abuse, misuse and dependence have come to the attention of authorities. In view of …
Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes
JL Norman, DR Fixen, JJ Saseen… - SAGE Open …, 2017 - journals.sagepub.com
Background: Women have higher morning serum zolpidem concentrations than men after
taking an evening dose, potentially leading to increased risk of harm. On 19 April 2013, the …
taking an evening dose, potentially leading to increased risk of harm. On 19 April 2013, the …